European Archives - Page 681 of 1561 - European Medical Journal

Optical Coherence Tomography for Stent Guidance Improves Outcomes in Complex PCI Cases: ESC 2024

ESC 2024: OCT-guided PCI in complex lesions reduced cardiac risks by 38% and spontaneous MI by 64% versus angiography, according to the OCCUPI trial.

Wearable ECG Device for Atrial Fibrillation Screening: ESC 2024

Atrial fibrillation screening using a 14-day wearable heart monitor patch significantly increased diagnoses compared to usual care, according to research presented at ESC 2024.

Could AI Diagnose Coronary Artery Disease? ESC 2024

The PROTEUS trial, presented at ESC 2024, evaluated the effectiveness of AI in standardizing clinician decision-making during stress echocardiography for coronary artery disease

stamp of approval

Second mpox vaccine wins FDA approval

The FDA has formally approved Emergent BioSolutions’ smallpox and mpox vaccine for use in preventing the virus in people at high risk of infection.

Common Antibiotics Linked to Risk of Life-Threatening Reactions

New study shows sulfonamides and cephalosporins carry the highest risk for serious cutaneous adverse drug reactions among antibiotics, particularly in older adults.

Barrett’s Oesophagus After Sleeve Gastrectomy: Is There a Risk?

Recent research highlights a significant increase in the risk of Barrett’s esophagus following sleeve gastrectomy, a commonly performed bariatric surgery

Liberal Transfusion Shows Comparable Outcomes in Brain Injury Recovery

A recent study finds that a liberal transfusion strategy does not improve neurological outcomes in critically ill patients with traumatic brain injury compared to a restrictive approach.

Intestinal Ultrasound Predicts Treatment Success in Paediatric Ulcerative Colitis

A study highlights the potential of intestinal ultrasound as a valuable tool for predicting treatment outcomes in children with moderate-to-severe ulcerative colitis.

Acute Myeloid Leukaemia Treatment Assessed for Patients Over 80

A multicentre study reveals the efficacy of Venetoclax with hypomethylating agents in treating acute myeloid leukemia in patients aged 80 and older.

Vutrisiran Reduces Mortality in Patients with Transthyretin Amyloidosis: ESC 2024

Presented at ESC 2024, vutrisiran, an RNAi therapeutic, significantly reduced mortality and cardiovascular events in patients with ATTR-CM.